163 related articles for article (PubMed ID: 37190129)
1. Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
Boraschi P; Moretto R; Donati F; Borelli B; Mercogliano G; Giugliano L; Boccaccino A; Della Pina MC; Colombatto P; Signori S; Masi G; Cremolini C; Urbani L
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190129
[TBL] [Abstract][Full Text] [Related]
2. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
[TBL] [Abstract][Full Text] [Related]
3. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review.
Barimani D; Kauppila JH; Sturesson C; Sparrelid E
World J Surg Oncol; 2020 Oct; 18(1):264. PubMed ID: 33032620
[TBL] [Abstract][Full Text] [Related]
4. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.
Sturesson C; Nilsson J; Lindell G; Andersson RG; Keussen I
HPB (Oxford); 2015 Nov; 17(11):983-7. PubMed ID: 26252426
[TBL] [Abstract][Full Text] [Related]
5. Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.
Owen JW; Fowler KJ; Doyle MB; Saad NE; Linehan DC; Chapman WC
HPB (Oxford); 2016 Mar; 18(3):296-303. PubMed ID: 27017170
[TBL] [Abstract][Full Text] [Related]
6. When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy.
Muaddi H; Silva S; Choi WJ; Coburn N; Hallet J; Law C; Cheung H; Karanicolas PJ
Ann Surg Oncol; 2021 Oct; 28(11):6805-6813. PubMed ID: 33772391
[TBL] [Abstract][Full Text] [Related]
7. Disappearing liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Paredes AZ; Moris D; Gavriatopoulou M; Cloyd JM; Pawlik TM
Surg Oncol; 2019 Jun; 29():7-13. PubMed ID: 31196496
[TBL] [Abstract][Full Text] [Related]
8. Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster?
Anselmo A; Cascone C; Siragusa L; Sensi B; Materazzo M; Riccetti C; Bacchiocchi G; Ielpo B; Rosso E; Tisone G
Healthcare (Basel); 2022 Sep; 10(10):. PubMed ID: 36292345
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
10. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference.
Wagner M; Maggiori L; Ronot M; Paradis V; Vilgrain V; Panis Y; Van Beers BE
Eur Radiol; 2013 Aug; 23(8):2156-64. PubMed ID: 23455763
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
Vilgrain V; Esvan M; Ronot M; Caumont-Prim A; Aubé C; Chatellier G
Eur Radiol; 2016 Dec; 26(12):4595-4615. PubMed ID: 26883327
[TBL] [Abstract][Full Text] [Related]
13. [Clinical research progress on disappearing colorectal liver metastases].
Pan SR; Chen ZY; Zhao K; Liu YC; Wang PY
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):1028-1034. PubMed ID: 34823305
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
[TBL] [Abstract][Full Text] [Related]
15. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
16. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M
Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173
[TBL] [Abstract][Full Text] [Related]
18. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.
Auer RC; White RR; Kemeny NE; Schwartz LH; Shia J; Blumgart LH; Dematteo RP; Fong Y; Jarnagin WR; D'Angelica MI
Cancer; 2010 Mar; 116(6):1502-9. PubMed ID: 20120032
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
[TBL] [Abstract][Full Text] [Related]
20. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]